Saraswat, A.; Nomani, A.; Yong, L.-K.; Kuo, J.C.-T.; Brown, H.; Narayanareddygari, M.; Peace, A.; Fazily, R.; Blake, T.; Petro, C.D.;
et al. A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2. Pharmaceutics 2025, 17, 441.
https://doi.org/10.3390/pharmaceutics17040441
AMA Style
Saraswat A, Nomani A, Yong L-K, Kuo JC-T, Brown H, Narayanareddygari M, Peace A, Fazily R, Blake T, Petro CD,
et al. A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2. Pharmaceutics. 2025; 17(4):441.
https://doi.org/10.3390/pharmaceutics17040441
Chicago/Turabian Style
Saraswat, Aishwarya, Alireza Nomani, Lin-Kin Yong, Jimmy Chun-Tien Kuo, Heather Brown, Muralikrishna Narayanareddygari, Avery Peace, Rizan Fazily, Timothy Blake, Christopher D. Petro,
and et al. 2025. "A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2" Pharmaceutics 17, no. 4: 441.
https://doi.org/10.3390/pharmaceutics17040441
APA Style
Saraswat, A., Nomani, A., Yong, L.-K., Kuo, J. C.-T., Brown, H., Narayanareddygari, M., Peace, A., Fazily, R., Blake, T., Petro, C. D., Rayaprolu, B., Hansen, J., Bhalla, A. S., & Shameem, M.
(2025). A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2. Pharmaceutics, 17(4), 441.
https://doi.org/10.3390/pharmaceutics17040441
